Richard B. Bartram
Net Worth

Last updated:

What is Richard B. Bartram net worth?

The estimated net worth of Mr. Richard B. Bartram is at least $4,076,090 as of 3 Apr 2019. He owns shares worth $22,520 as insider, has earned $345,320 from insider trading and has received compensation worth at least $3,708,250 in Esperion Therapeutics, Inc..

What is the salary of Richard B. Bartram?

Mr. Richard B. Bartram salary is $529,750 per year as Chief Financial Officer & Corporation Sec. in Esperion Therapeutics, Inc..

How old is Richard B. Bartram?

Mr. Richard B. Bartram is 43 years old, born in 1982.

What stocks does Richard B. Bartram currently own?

As insider, Mr. Richard B. Bartram owns shares in one company:

Company Title Shares Price per share Total value
Esperion Therapeutics, Inc. (ESPR) Chief Financial Officer & Corporation Sec. 11,092 $2.03 $22,520

What does Esperion Therapeutics, Inc. do?

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Richard B. Bartram insider trading

Esperion Therapeutics, Inc.

Mr. Richard B. Bartram has made only one insider trade between 2018-2019, according to the Form 4 filled with the SEC. He sold 8,000 units of ESPR stock worth $345,320 on 3 Apr 2019.

As of 3 Apr 2019 he still owns at least 11,092 units of ESPR stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 8,000 $43.17 $345,320
Option
Stock Option (right to buy) 17,892 $3.7 $66,200
Option
Common Stock 17,892 $3.7 $66,200

Esperion Therapeutics key executives

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC: